Thermo Fisher Scientific (TMO)
Supplies laboratory tools, diagnostics, and outsourced drug-development and manufacturing services.
$659.68
vs last close+0.92 (+0.14%)
Something off on this page? Send us feedback.
Next report
Oct 28, 26
in 36 days
EPS estimate
$6.40
Revenue estimate
$11.95B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$6.10$5.15$5.36$5.79$6.57$5.44$6.03Pending
Estimate$5.94$5.10$5.23$5.50$6.45$5.25$5.72$6.40
Surprise+2.7%+1.0%+2.5%+5.3%+1.9%+3.6%+5.4%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$11.40B$10.36B$10.86B$11.12B$12.22B$11.01B$11.99BPending
Estimate$11.28B$10.23B$10.68B$10.92B$11.95B$10.86B$11.71B$11.95B
Surprise+1.0%+1.3%+1.6%+1.9%+2.2%+1.3%+2.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $8.71 | — | — |
| Sep 2028 | $7.59 | — | — |
| Jun 2028 | $7.11 | — | — |
| Mar 2028 | $6.73 | — | — |
| Dec 2027 | $7.85 | — | — |
| Sep 2027 | $6.91 | — | — |
| Jun 2027 | $6.59 | — | — |
| Mar 2027 | $5.99 | — | — |
| Dec 2026 | $7.26 | — | — |
| Oct 2026 | $6.40 | — | — |
| Jul 2026 | $5.72 | $6.03 | +5.4% |
| Apr 2026 | $5.25 | $5.44 | +3.6% |
| Jan 2026 | $6.45 | $6.57 | +1.9% |
| Oct 2025 | $5.50 | $5.79 | +5.3% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $8.71 | — | — | $14.69B | — | — | — |
| Sep 2028 | $7.59 | — | — | $13.37B | — | — | — |
| Jun 2028 | $7.11 | — | — | $13.06B | — | — | — |
| Mar 2028 | $6.73 | — | — | $12.57B | — | — | — |
| Dec 2027 | $7.85 | — | — | $13.51B | — | — | — |
| Sep 2027 | $6.91 | — | — | $12.49B | — | — | — |
| Jun 2027 | $6.59 | — | — | $12.44B | — | — | — |
| Mar 2027 | $5.99 | — | — | $11.73B | — | — | — |
| Dec 2026 | $7.26 | — | — | $12.90B | — | — | — |
| Oct 28, 2026 | $6.40 | — | — | $11.95B | — | — | — |
| Jul 23, 2026 | $5.72 | $6.03 | +5.4% | $11.71B | $11.99B | +2.5% | +8.7% |
| Apr 23, 2026 | $5.25 | $5.44 | +3.6% | $10.86B | $11.01B | +1.3% | −9.2% |
| Jan 29, 2026 | $6.45 | $6.57 | +1.9% | $11.95B | $12.22B | +2.2% | −2.6% |
| Oct 22, 2025 | $5.50 | $5.79 | +5.3% | $10.92B | $11.12B | +1.9% | +1.7% |
| Jul 23, 2025 | |||||||
| Apr 23, 2025 | |||||||
| Jan 30, 2025 | |||||||
| Oct 23, 2024 | |||||||
| Jul 24, 2024 | |||||||
| Apr 24, 2024 | |||||||
| Jan 31, 2024 | |||||||
| Oct 25, 2023 | |||||||
| Jul 26, 2023 | |||||||
| Apr 26, 2023 | |||||||
| Feb 1, 2023 | |||||||
| Oct 26, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Apr 28, 2022 | |||||||
| Feb 2, 2022 | |||||||
| Oct 27, 2021 | |||||||
| Jul 28, 2021 | |||||||
| Apr 29, 2021 | |||||||
| Feb 1, 2021 | |||||||
| Oct 21, 2020 | |||||||
| Jul 22, 2020 | |||||||
| Apr 22, 2020 | |||||||
| Jan 30, 2020 | |||||||
| Oct 23, 2019 | |||||||
| Jul 24, 2019 | |||||||
| Apr 24, 2019 | |||||||
| Jan 30, 2019 | |||||||
| Oct 24, 2018 | |||||||
| Jul 25, 2018 | |||||||
| Apr 25, 2018 | |||||||
| Jan 31, 2018 | |||||||
| Oct 25, 2017 | |||||||
| Jul 26, 2017 | |||||||
| Apr 26, 2017 | |||||||
| Jan 31, 2017 | |||||||
| Oct 27, 2016 | |||||||
| Jul 28, 2016 | |||||||
| Apr 28, 2016 | |||||||
| Jan 28, 2016 | |||||||
| Oct 21, 2015 | |||||||
| Jul 22, 2015 |